Chen, T., Deng, Z., Zhao, R., Shen, H., & Li, W. (2018). SYKT Alleviates Doxorubicin-Induced Cardiotoxicity via Modulating ROS-Mediated p53 and MAPK Signal Pathways. Evid Based Complement Alternat Med.
Styl ChicagoChen, Ting, Zhiyong Deng, Ruilian Zhao, Hongmei Shen, a Wenhui Li. "SYKT Alleviates Doxorubicin-Induced Cardiotoxicity Via Modulating ROS-Mediated P53 and MAPK Signal Pathways." Evid Based Complement Alternat Med 2018.
Citace podle MLAChen, Ting, et al. "SYKT Alleviates Doxorubicin-Induced Cardiotoxicity Via Modulating ROS-Mediated P53 and MAPK Signal Pathways." Evid Based Complement Alternat Med 2018.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..